Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease

Clinical trial NCT07294586 · COMPLETED

Trial details

NCT number: NCT07294586
Sponsor: Amoneta Diagnostics SAS
Status: COMPLETED
Study type: OBSERVATIONAL

Alzheimer Disease Dementia Neurodegenerative Disorders Cognitive Decline Memory Loss Mild Cognitive Impairment (MCI)Early Onset Alzheimer Disease Late Onset Alzheimer Disease

Start date: 2019-10-28
Primary completion: 2019-10-28
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.